PRIMARY PERITONEAL
Clinical trials for PRIMARY PERITONEAL explained in plain language.
Never miss a new study
Get alerted when new PRIMARY PERITONEAL trials appear
Sign up with your email to follow new studies for PRIMARY PERITONEAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for hard-to-treat ovarian cancer: targeted drug enters phase 2 trial
Disease control Recruiting nowThis study tests a drug called TORL-1-23 in 230 women with advanced ovarian, fallopian tube, or peritoneal cancer that no longer responds to platinum chemotherapy and has a specific marker (claudin 6). The goal is to see if the drug can shrink tumors and how safe it is. Participa…
Matched conditions: PRIMARY PERITONEAL
Phase: PHASE2 • Sponsor: TORL Biotherapeutics, LLC • Aim: Disease control
Last updated May 26, 2026 05:55 UTC
-
New drug shows promise for tough ovarian cancer
Disease control Recruiting nowThis study tests a drug called mirvetuximab soravtansine in people with ovarian, peritoneal, or fallopian tube cancer that has stopped responding to platinum chemotherapy and has high levels of a protein called FRα. The drug delivers a cancer-killing agent directly to tumor cells…
Matched conditions: PRIMARY PERITONEAL
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Antifungal interaction study launched for ovarian cancer drug
Knowledge-focused Recruiting nowThis study looks at how the antifungal drug itraconazole changes the way the body processes a cancer drug called AZ14170132, which is part of a targeted therapy for ovarian, peritoneal, and fallopian tube cancers. About 24 people with these cancers will take both drugs in a fixed…
Matched conditions: PRIMARY PERITONEAL
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 26, 2026 05:54 UTC